347 related articles for article (PubMed ID: 32841068)
1. Potential role of drug metabolizing enzymes in chemotherapy-induced gastrointestinal toxicity and hepatotoxicity.
Tao G; Huang J; Moorthy B; Wang C; Hu M; Gao S; Ghose R
Expert Opin Drug Metab Toxicol; 2020 Nov; 16(11):1109-1124. PubMed ID: 32841068
[TBL] [Abstract][Full Text] [Related]
2. Role of Drug-metabolizing Enzymes in Cancer and Cancer Therapy.
Feng S; Li A; Zheng YC; Liu HM
Curr Drug Metab; 2020; 21(1):67-76. PubMed ID: 31902352
[TBL] [Abstract][Full Text] [Related]
3. Prediction of metabolism-induced hepatotoxicity on three-dimensional hepatic cell culture and enzyme microarrays.
Yu KN; Nadanaciva S; Rana P; Lee DW; Ku B; Roth AD; Dordick JS; Will Y; Lee MY
Arch Toxicol; 2018 Mar; 92(3):1295-1310. PubMed ID: 29167929
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
Rushmore TH; Kong AN
Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
[TBL] [Abstract][Full Text] [Related]
5. Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.
Hattinger CM; Serra M
Expert Opin Drug Metab Toxicol; 2015; 11(9):1449-63. PubMed ID: 26095223
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced hepatotoxicity in cancer patients - implication for treatment.
Vincenzi B; Armento G; Spalato Ceruso M; Catania G; Leakos M; Santini D; Minotti G; Tonini G
Expert Opin Drug Saf; 2016 Sep; 15(9):1219-38. PubMed ID: 27232067
[TBL] [Abstract][Full Text] [Related]
7. Relationship Between the Gut Microbiome and Systemic Chemotherapy.
Ervin SM; Ramanan SV; Bhatt AP
Dig Dis Sci; 2020 Mar; 65(3):874-884. PubMed ID: 32026181
[TBL] [Abstract][Full Text] [Related]
8. Effect of YH0618 soup on chemotherapy-induced toxicity in patients with cancer who have completed chemotherapy: study protocol for a randomized controlled trial.
You JS; Chen JP; Chan JS; Lee HF; Wong MK; Yeung WF; Lao LX
Trials; 2016 Jul; 17(1):354. PubMed ID: 27457560
[TBL] [Abstract][Full Text] [Related]
9. Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology.
Prandota J
Am J Ther; 2005; 12(3):254-61. PubMed ID: 15891270
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy-induced liver injury in children].
Urrutia-Maldonado E; Abril-Molina A; Alés-Palmer M; Gómez-Luque JM; Muñoz de Rueda P; Ocete-Hita E
An Pediatr (Engl Ed); 2019 Oct; 91(4):256-263. PubMed ID: 30777719
[TBL] [Abstract][Full Text] [Related]
11. Upgrading HepG2 cells with adenoviral vectors that encode drug-metabolizing enzymes: application for drug hepatotoxicity testing.
Gómez-Lechón MJ; Tolosa L; Donato MT
Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):137-148. PubMed ID: 27671376
[TBL] [Abstract][Full Text] [Related]
12. An overview of acute gastrointestinal side effects of systemic anti-cancer therapy and their management.
Smith P; Lavery A; Turkington RC
Best Pract Res Clin Gastroenterol; 2020; 48-49():101691. PubMed ID: 33317796
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal toxicity of chemotherapeutic agents.
Mitchell EP
Semin Oncol; 2006 Feb; 33(1):106-20. PubMed ID: 16473649
[TBL] [Abstract][Full Text] [Related]
14. Regulation of drug-metabolizing enzymes by local and systemic liver injuries.
Guo Y; Hu B; Xie Y; Billiar TR; Sperry JL; Huang M; Xie W
Expert Opin Drug Metab Toxicol; 2016; 12(3):245-51. PubMed ID: 26751558
[TBL] [Abstract][Full Text] [Related]
15. Hepatotoxicity of targeted therapy for cancer.
Lee KW; Chan SL
Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):789-802. PubMed ID: 27187715
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal and liver adverse effects of drugs used for treating IBD.
Rogler G
Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):157-65. PubMed ID: 20227029
[TBL] [Abstract][Full Text] [Related]
17. [Hepatotoxicity of chemotherapy].
Sato Y; Kato J
Nihon Rinsho; 2015 Feb; 73 Suppl 2():369-74. PubMed ID: 25831785
[No Abstract] [Full Text] [Related]
18. Metabolic bioactivation of antidepressants: advance and underlying hepatotoxicity.
Khalil SM; MacKenzie KR; Maletic-Savatic M; Li F
Drug Metab Rev; 2024; 56(2):97-126. PubMed ID: 38311829
[TBL] [Abstract][Full Text] [Related]
19. The use of SAMe in chemotherapy-induced liver injury.
Vincenzi B; Russo A; Terenzio A; Galvano A; Santini D; Vorini F; Antonelli-Incalzi R; Vespasiani-Gentilucci U; Tonini G
Crit Rev Oncol Hematol; 2018 Oct; 130():70-77. PubMed ID: 30196914
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review.
Raju B; Choudhary S; Narendra G; Verma H; Silakari O
Drug Metab Rev; 2021 Feb; 53(1):45-75. PubMed ID: 33535824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
